Johnson & Johnson (BIT:1JNJ)

Market Cap	312.99B
Revenue (ttm)	82.47B
Net Income (ttm)	20.13B
Shares Out	n/a
EPS (ttm)	8.29
PE Ratio	15.54
Forward PE	14.38
Dividend	3.48 (2.67%)
Ex-Dividend Date	Feb 17, 2025

Volume	60
Average Volume	92
Open	130.88
Previous Close	130.32
Day's Range	130.38 - 131.06
52-Week Range	128.30 - 162.26
Beta	n/a
RSI	36.39
Earnings Date	Jul 16, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD